Jeffrey Matous, MD

Financial relationships

  • Attribution: 
    Self
    Nature of financial relationship: 
    Professional Services
    Ineligible company: 
    Janssen Pharmacyclic's
    Topic: 
    Advisory board
    Date added: 
    05/01/2023
    Relationship end date: 
    12/31/2023
  • Attribution: 
    Self
    Nature of financial relationship: 
    Professional Services
    Ineligible company: 
    BeiGene
    Topic: 
    Advisory Board
    Date added: 
    05/01/2023
    Relationship end date: 
    12/31/2023
Return to 13th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego